A new study from researchers at the UCLA Jonsson Comprehensive Cancer Center helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade, and how new drug combinations ...
May 28, 2020
0
1
A team of scientists from Hollings Cancer Center at the Medical University of South Carolina (MUSC) has developed a novel flow cytometry technique that can, for the first-time, quantify protein production in T-cells. T cells ...
May 20, 2020
0
58
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.
May 11, 2020
0
6
Rapidly increasing cancer incidence and mortality worldwide have raised great challenges for the currently available anticancer options, which warrants the development of new therapeutic modalities based on novel antitumor ...
Apr 29, 2020
0
1
How does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the spatiotemporal activity of tumor-infiltrating T lymphocytes, both locally ...
Mar 12, 2020
0
211
Aggressive colorectal cancers set up an interactive network of checkpoints to keep the immune system at bay, scientists report.
Feb 26, 2020
0
78
A merger of math and medicine may help to improve the efficacy of immunotherapies, potentially life-saving treatments that enhance the ability of the patient's own immune system to attack cancerous tumors.
Feb 3, 2020
0
129
Melding the genetic and cellular analysis of tumors with how they appear in medical images could give physicians and other cancer therapy specialists new insights into how to best treat patients, especially those with brain ...
Jan 30, 2020
0
1
A new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) reveals how a clotting protein and blood ...
Jan 14, 2020
0
125
UT Southwestern researchers have developed a software tool that uses artificial intelligence to recognize cancer cells from digital pathology images—giving clinicians a powerful way of predicting patient outcomes.
Dec 9, 2019
0
26
